These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35899362)

  • 1. From novel discovery tools and biomarkers to precision medicine-basic cardiovascular science highlights of 2021/22.
    Evans PC; Davidson SM; Wojta J; Bäck M; Bollini S; Brittan M; Catapano AL; Chaudhry B; Cluitmans M; Gnecchi M; Guzik TJ; Hoefer I; Madonna R; Monteiro JP; Morawietz H; Osto E; Padró T; Sluimer JC; Tocchetti CG; Van der Heiden K; Vilahur G; Waltenberger J; Weber C
    Cardiovasc Res; 2022 Oct; 118(13):2754-2767. PubMed ID: 35899362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Management of Cardiovascular Disorders.
    Jain KK
    Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
    de Gonzalo-Calvo D; Vea A; Bär C; Fiedler J; Couch LS; Brotons C; Llorente-Cortes V; Thum T
    Eur Heart J; 2019 May; 40(20):1643-1650. PubMed ID: 29688487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.
    Barbato E; Barton PJ; Bartunek J; Huber S; Ibanez B; Judge DP; Lara-Pezzi E; Stolen CM; Taylor A; Hall JL
    J Cardiovasc Transl Res; 2015 Nov; 8(8):466-74. PubMed ID: 26453460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases.
    Wang RS; Maron BA; Loscalzo J
    Arterioscler Thromb Vasc Biol; 2023 Apr; 43(4):493-503. PubMed ID: 36794589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology.
    Kirchhof P; Sipido KR; Cowie MR; Eschenhagen T; Fox KA; Katus H; Schroeder S; Schunkert H; Priori S;
    Eur Heart J; 2014 Dec; 35(46):3250-7. PubMed ID: 25148837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Medicine and Personalized Medicine in Cardiovascular Disease.
    Currie G; Delles C
    Adv Exp Med Biol; 2018; 1065():589-605. PubMed ID: 30051409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omics technologies in personalized combination therapy for cardiovascular diseases: challenges and opportunities.
    Banerjee S; Prabhu Basrur N; Rai PS
    Per Med; 2021 Sep; 18(6):595-611. PubMed ID: 34689602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personalized therapy in cardiology. Biomarkers, pharmacogenetics and therapy of monogenic diseases].
    Eschenhagen T; Blankenberg S
    Internist (Berl); 2013 Feb; 54(2):147-8, 150-2, 154. PubMed ID: 23371262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing Single-Cell RNA Sequencing to Better Understand How Diseased Cells Behave the Way They Do in Cardiovascular Disease.
    Iqbal F; Lupieri A; Aikawa M; Aikawa E
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):585-600. PubMed ID: 33327741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome of blood cells as a reservoir of cardiovascular biomarkers.
    Devaux Y
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):209-216. PubMed ID: 27836747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
    Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
    Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring predisposition and treatment response--the promise of genomics.
    Pan S; Knowles JW
    Prog Cardiovasc Dis; 2012; 55(1):56-63. PubMed ID: 22824110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
    Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
    Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid-based assays and precision medicine of cardiovascular diseases: the 'hope' for Pandora's box?
    Benincasa G; Mansueto G; Napoli C
    J Clin Pathol; 2019 Dec; 72(12):785-799. PubMed ID: 31611285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.
    Chen IY; Matsa E; Wu JC
    Nat Rev Cardiol; 2016 Jun; 13(6):333-49. PubMed ID: 27009425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases.
    Schiano C; Benincasa G; Franzese M; Della Mura N; Pane K; Salvatore M; Napoli C
    Pharmacol Ther; 2020 Jun; 210():107514. PubMed ID: 32105674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengths and Opportunities of Network Medicine in Cardiovascular Diseases.
    Benincasa G; Marfella R; Della Mura N; Schiano C; Napoli C
    Circ J; 2020 Jan; 84(2):144-152. PubMed ID: 31866635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical epigenomics for cardiovascular disease: Diagnostics and therapies.
    Fischer MA; Vondriska TM
    J Mol Cell Cardiol; 2021 May; 154():97-105. PubMed ID: 33561434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases.
    Zhao G
    J Med Genet; 2018 Nov; 55(11):713-720. PubMed ID: 30177556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.